We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+32.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$703M
AUM Growth
+$202M
Cap. Flow
+$117M
Cap. Flow %
16.67%
Top 10 Hldgs %
43.13%
Holding
134
New
60
Increased
28
Reduced
13
Closed
31

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$12.9M
2
XRAY icon
Dentsply Sirona
XRAY
+$9.25M
3
BSX icon
Boston Scientific
BSX
+$7.14M
4
VRAY
ViewRay, Inc.
VRAY
+$7.09M
5
GILD icon
Gilead Sciences
GILD
+$6.65M

Top Sells

Rank Stock Value
1
SIBN icon
SI-BONE Inc
SIBN
+$4.49M
2
AMGN icon
Amgen
AMGN
+$3.89M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.33M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$2.99M
5
AMRN
Amarin Corp
AMRN
+$2.78M

Sector Composition

Rank Sector Weight
1 Healthcare 36.29%
2 Industrials 0.63%
3 Financials 0.27%
4 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMGI
51
DELISTED
Wright Medical Group Inc
WMGI
$4.4M 0.63%
140,000
-71,200
-34% -$2.16M
IONS icon
52
PUT
Ionis Pharmaceuticals
IONS
$9.21B
$4.06M 0.58%
+50,000
New +$3.23M
GMED icon
53
Globus Medical
GMED
$11.4B
$3.95M 0.56%
+80,000
New +$3.62M
LIVN icon
54
LivaNova
LIVN
$4.33B
$3.89M 0.55%
40,000
– –
AVNS
55
DELISTED
Avanos Medical
AVNS
$3.73M 0.53%
87,500
+54,825
+168% +$2.45M
BDSI
56
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$3.71M 0.53%
700,478
+77,556
+12% +$354K
ABBV icon
57
AbbVie
ABBV
$442B
$3.63M 0.52%
+44,980
New +$3.68M
WMGI
58
CALL
DELISTED
Wright Medical Group Inc
WMGI
$3.54M 0.5%
+112,500
New +$3.42M
CNMD icon
59
CONMED
CNMD
$1.48B
$3.33M 0.47%
+40,000
New +$2.91M
VAPO
60
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$3.31M 0.47%
21,022
+2,328
+12% +$334K
EHC icon
61
PUT
Encompass Health
EHC
$12.4B
$3.28M 0.47%
+70,643
New +$3.58M
XENT
62
CALL
DELISTED
Intersect ENT, Inc
XENT
$3.21M 0.46%
+100,000
New +$3.09M
TDOC icon
63
Teladoc Health
TDOC
$1.24B
$3.2M 0.45%
+57,500
New +$3.51M
PTCT icon
64
PTC Therapeutics
PTCT
$6.15B
$3.17M 0.45%
+84,338
New +$2.83M
SWAV
65
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$3.09M 0.44%
+92,400
New +$3.07M
AXSM icon
66
Axsome Therapeutics
AXSM
$11.1B
$3.04M 0.43%
+213,645
New +$1.98M
ZGNX
67
DELISTED
Zogenix, Inc.
ZGNX
$2.96M 0.42%
53,718
+4,831
+10% +$230K
CNCE
68
CALL
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2.71M 0.39%
+224,900
New +$3.31M
OTIC
69
DELISTED
Otonomy, Inc.
OTIC
$2.61M 0.37%
993,463
+97,076
+11% +$219K
TNDM icon
70
Tandem Diabetes Care
TNDM
$1.63B
$2.54M 0.36%
40,000
-56,914
-59% -$2.99M
KALA icon
71
KALA BIO
KALA
$16.3M
$2.47M 0.35%
120
+34
+40% +$604K
INCY icon
72
Incyte
INCY
$24.5B
$2.44M 0.35%
28,318
-26,889
-49% -$2.19M
SIEN
73
PUT
DELISTED
Sientra, Inc.
SIEN
$2.41M 0.34%
28,120
-26,880
-49% -$3.01M
CHRS icon
74
Coherus Oncology
CHRS
$187M
$2.26M 0.32%
165,613
-45,458
-22% -$607K
AXSM icon
75
CALL
Axsome Therapeutics
AXSM
$11.1B
$2.24M 0.32%
157,400
+83,400
+113% +$774K
1 2
3
4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2019 Portfolio in Review

As of Q1 2019, Pura Vida Investments held 134 positions worth $703M, up 40% from $501M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments deployed $117M of net new capital in Q1 2019, opening 60 new positions and adding to 28 existing holdings. Its largest new stake was Zimmer Biomet: 113,300 shares worth $14M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Tandem Diabetes Care, an estimated $2.99M trimmed.

  • Pura Vida Investments's largest Q1 2019 buy was Zimmer Biomet: 113,300 shares worth $14M.
  • Pura Vida Investments added most to Boston Scientific in Q1 2019, an estimated $7.14M increase.
  • Pura Vida Investments's biggest Q1 2019 reduction was Tandem Diabetes Care, cutting an estimated $2.99M.
  • Pura Vida Investments fully exited SI-BONE Inc in Q1 2019, selling an estimated $4.49M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $703M portfolio in Q1 2019.
  • Pura Vida Investments opened 60 new positions and closed 31 in Q1 2019.
  • Pura Vida Investments's portfolio value rose 40% quarter-over-quarter to $703M.

Based on Pura Vida Investments's 13F filing for Q1 2019, filed 14 May 2019.